Virksomhedens formål er at udvikle lægemidler samen anden hermed forbunden virksomhed.
| Year | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2024 | 74.3 mio. | -12.5 mio. | 26.5 mio. | -125.2 mio. | 56 | |
CVR: 37053678
Compared to 994 companies in Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Comparison is based on industry median values
Companies in the same industry and area
CVR 31591414
CVR 29312206
CVR 29829586
CVR 32551475
CVR 38892304
EY Godkendt Revisionspartnerselskab appointed as auditor
PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB resigned as auditor
Antoine Bernasconi joined the board
Vincent Sainte-Catherine joined the board
Julien Forest joined the board
Johan Ernst Wedell-Wedellsborg left the board
Thomas Gad left the board
Michael Joseph Rossi left the board
Peter Paul Pfreundschuh left the board
Vincent Sainte-Catherine joined as ADM. DIR.
companydata.dk